Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of November 28, 2021
Repairing the damage: regeneration of the mouse thymus
From the Dudakov Lab, Clinical Research Division
Thwarting relapse in patients with acute myeloid leukemia
From the Hill Lab, Clinical Research Division
Investigating the emergence of hematopoietic stem cells in a mouse embryo
From the Hadland Lab, Clinical Research Division
Nanoreagents for improving inflammation in auto-immune disease
From the Stephan Lab, Clinical Research Division
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
When life science gives you lemons: T cells as a vaccine platform
From the Riddell Lab, Clinical Research Division
Measure 170 times, cut once: high-throughput drug screening for multiple myeloma
From Dr. Pamela Becker and Dr. David Coffey, Clinical Research Division
Keeping regular: gut bacteria modulate transit time via bile acids
From the Dey Lab, Clinical Research Division
New study finds many cancer patients have no antibodies to measles or mumps
Hospital study shows younger adults, stem cell transplant recipients more likely to have less protection
A lasting impression: CMV exposure imprints donor T cell phenotypes
From the Hill Lab, Clinical Research Division
Alter ego: RNA helicase is recruited to sites of DNA damage
From the Warren Lab, Clinical Research Division
Methods for the masses: multiplexed growth signaling analyses by mass spec
From the Paulovich Lab, Clinical Research Division, and colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
One patient’s fight against gastrointestinal stromal tumors
From the Pollack lab, Clinical Research Division
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
Reprograming macrophages with nanoparticles
From the Stephan Lab, Clinical Research Division
Cells from baby and rheumatoid arthritis
From the Nelson lab, Clinical Research Division
Eliminating residual multiple myeloma with precision
From the Green Lab, Clinical Research Division
Colon cancer risk and senescence-associated colon microenvironment
From the Grady Lab, Clinical Research Division
Gene-modified cells in the brain
From the Kiem Lab, Clinical Research Division